Product image of Levetiracetam Exeltis (Levetiracetam) supplied by GNH India

Levetiracetam Exeltis

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Exeltis (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Exeltis, is an anticonvulsant presented as an oral tablet for oral use. It is employed to manage various seizure types in patients with epilepsy, including partial‑onset, generalized tonic‑clonic, and myoclonic seizures, and is approved for use in adult and pediatric populations.

GNH India supplies Levetiracetam Exeltis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for essential antiepileptic medicines across global markets.

Manufacturer / TM Owner

Exeltis Healthcare S.L

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levetiracetam is an antiepileptic agent used to control seizure activity in epilepsy.
  • Partial‑onset seizures: decreases the number and severity of focal seizures in individuals diagnosed with epilepsy.
  • Generalized tonic‑clonic seizures: lowers the occurrence of bilateral convulsive seizures, improving overall seizure control.
  • Myoclonic seizures: reduces the frequency of rapid, involuntary muscle jerks characteristic of myoclonic epilepsy.
  • Adjunct therapy: can be combined with other antiepileptic drugs to enhance overall seizure management.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, a regulator of neurotransmitter release. This interaction modulates vesicle exocytosis, stabilizing neuronal membranes and reducing hyper‑excitable synaptic transmission. By decreasing the release of excitatory neurotransmitters, the drug lowers neuronal firing rates that underlie seizure generation. The precise downstream pathways remain under investigation, but the net effect is a dampening of abnormal electrical activity across cortical networks.

Side Effects

Levetiracetam may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Dizziness: feeling of light‑headedness or unsteadiness.
  • Fatigue: persistent tiredness not relieved by rest.
  • Headache: mild to moderate cranial pain.
  • Irritability: increased emotional sensitivity or agitation.

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis): rapid onset of hives, swelling, and breathing difficulty.
  • Stevens‑Johnson syndrome: serious skin reaction with blistering and detachment.
  • Suicidal thoughts or behavior: emergence of depressive symptoms or urges to self‑harm.

Precautions & Warnings

  • When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.
  • Renal impairment: adjust dose based on creatinine clearance.
  • Hepatic dysfunction: monitor liver function tests periodically.
  • Mood changes: observe for depression, anxiety, or suicidal ideation.
  • Concomitant CNS depressants: use caution as additive sedation may occur.
  • Pregnancy: category B, discuss risk‑benefit with patient.
  • Store at ambient temperature: keep below 25°C in original container, protect from moisture.

Avoid Interactions

Levetiracetam can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma levels.
  • Phenobarbital: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely)

  • Alcohol: can enhance central nervous system depression.
  • Other antiepileptic drugs (e.g., valproate): may require dose adjustments.
  • Oral contraceptives: may have reduced effectiveness; monitor menstrual cycles.

Frequently Asked Questions

Levetiracetam Exeltis is prescribed to treat epilepsy by reducing the frequency of partial‑onset, generalized tonic‑clonic, and myoclonic seizures. It is used in both adult and pediatric patients when seizure control is needed as part of a comprehensive antiepileptic regimen.

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal membranes and diminishes excessive excitatory signaling, thereby lowering the likelihood of seizure‑triggering electrical discharges in the brain.

The appropriate dose of Levetiracetam Exeltis is individualized by the prescribing clinician based on factors such as the patient’s age, weight, renal function, seizure type, and response to therapy. No fixed dosing regimen is provided here.

Levetiracetam is classified as pregnancy category B, indicating that animal studies have not shown risk but there are limited human data. It may be used if the potential benefit justifies the potential risk. Breastfeeding decisions should be made after consulting a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers or GABA‑enhancers. It generally has a favorable drug‑interaction profile and does not require routine therapeutic drug monitoring, making it a convenient option for many patients compared with older agents.

Store the tablets at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children.

Levetiracetam Exeltis is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious adverse events, although rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and the emergence of suicidal thoughts or behaviors. Patients should be monitored closely for any signs of these conditions and seek immediate medical attention if they occur.

Levetiracetam is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. Caution is also advised for patients with severe renal impairment who may require dose adjustments, and for those with a history of psychiatric disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT